Related Experiment Video

Updated: Jun 13, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients

Elias E Mazokopakis1, Periklis K Syros, Ioannis K Starakis

  • 1Department of Internal Medicine, Naval Hospital of Crete, 73 200 Chania, Crete, Greece. emazokopakis@yahoo.gr

Cardiovascular & Hematological Disorders Drug Targets
|April 20, 2010
PubMed

Insights

Nonbacterial thrombotic endocarditis (NBTE), also known as marantic endocarditis, involves platelet aggregates on heart valves without bacterial infection. This rare condition is often linked to cancer and hypercoagulable states.

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Nonbacterial thrombotic endocarditis (NBTE), or marantic endocarditis, is characterized by platelet-rich vegetations on heart valves.
  • It occurs in the absence of bacterial infection and is frequently associated with hypercoagulable states or advanced malignancy.
  • NBTE commonly affects the aortic and mitral valves.

Purpose of the Study:

  • To review the pathogenesis, incidence, clinical manifestations, diagnosis, and management of NBTE.
  • To focus on NBTE specifically within the context of cancer patients.
  • To provide a comprehensive overview for clinicians managing this rare condition.

Main Methods:

  • Literature review of existing studies on NBTE.
  • Analysis of clinical data and case reports concerning NBTE in cancer patients.
  • Synthesis of information regarding the pathophysiology and clinical presentation of NBTE.

Main Results:

  • NBTE pathogenesis involves non-infectious thrombotic vegetations on heart valves.
  • Advanced malignancies, particularly adenocarcinomas, are significant risk factors for NBTE.
  • Clinical manifestations can range from asymptomatic to severe embolic events.

Conclusions:

  • NBTE is a rare but serious complication in cancer patients, often linked to malignancy-induced hypercoagulability.
  • Early diagnosis and appropriate management are crucial for improving outcomes in affected patients.
  • Further research into the specific mechanisms and targeted therapies for NBTE in oncology is warranted.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...